Curious if any of your clients received any benefit from long term use of S.boulardi?

Opinion on this link?

http://www.horizonpress.com/cimb/v/v11/47.pdf

Safety of administration
"S. boulardii is administrated to patients in a lyophilized
form and the treatment is well tolerated. However, some
rare cases of S. boulardii fungemias have been reported
in patients with an indwelling central venous catheter (de
Llanos et al., 2006; Hennequin et al., 2000; Lherm et al.,
2002). The origin of the fungemia is thought to be either
a digestive tract translocation or a contamination of the
central venous line by the colonized hands of health
workers (Hennequin et al., 2000). This raises the question
of the risk-benefit ratio of S. boulardii in critically ill or
immunocompromised patients. Thus, administration of S.
boulardii should be contraindicated for patients of fragile
health, as well as for patients with central venous catheter
(Herbrecht and Nivoix, 2005)."

So maybe if someone has too much fungal candida present the chemicals produced by the "fungal" candida can encourage S. boulardi to switch to its fungal form?

In the passage "fragile health" might refer to too much pathogens present or even fungal candida?? I agree-- lab results can be much more manipulated than what can actually happen in the gut environment.

Just seems like the composition of our gut flora works best when any type of yeast is down to the minimum.